Apheresis Devices Market Size 2024-2028

The global apheresis devices market size is estimated to grow by USD 1.59 million, at a CAGR of 8.45% between 2023 and 2028. 

Plasma products, derived from the blood of donors, serve as life-saving options for various medical conditions like trauma and disseminated intravascular coagulation (DIC). These products, including fresh-frozen plasma and solvent-treated plasma, correct deficiencies of clotting factors and are vital in treating neurological conditions and haematological disorders. Pharmaceutical companies are increasingly focusing on plasma-derived products for diverse therapeutic applications. Plasma can be collected as recovered plasma or source plasma, primarily through apheresis. The therapeutic plasma exchange process treats diseases like Guillain-Barre syndrome and Myasthenia gravis. Manufacturers in the market are developing advanced products to obtain source plasma, catering to specific disease indications. This trend of expanding indications for plasma products is expected to drive market growth during the forecast period.

What will be the Size of the Market During the Forecast Period?

To learn more about this report, Download Report Sample

Segmentation by Product, Application, and Geography Analysis

The market caters to various medical needs, particularly for patients with blood-related disorders such as leukemia, lymphoma, and myeloma. These devices play a crucial role in blood transfusions and managing conditions like autoimmune diseases and cancer. With the emergence of portable devices, treatments can now be administered conveniently outside of traditional healthcare settings. The market also sees significant demand for apheresis kits and apheresis equipment to facilitate clinical apheresis procedures and plasma therapy, including convalescent plasma therapy for conditions like SARS CoV2 infection. The Spectra Optia Apheresis System stands out as a prominent device for therapeutic purposes, offering efficient red blood cell exchange (RBCX) treatment and other therapeutic interventions. The use of advanced technologies such as membrane filtration and centrifugation equipment ensures precise and effective separation of blood components, addressing a wide range of blood disorders.

Product Analysis 

The market share growth by the systems segment will be significant during the forecast period. Apheresis systems are used to receive blood from donors or patients and separate it into various components such as plasma, platelets, red blood cells, and white blood cells. The systems used for the apheresis process are advanced with effective designs and features for providing required blood components to patients. Systems utilized for the process of separating or collecting specific blood components mainly use centrifugation or filtration technology.

Get a glance at the market contribution of various segments Download PDF Sample

The systems were the largest segment and were valued at USD 1.56 billion in 2018. Further, companies are focusing on the development of technologically advanced systems. For instance, Terumo Corp.s (Terumo) Spectra Optia is a technologically advanced system with a cell processing and cell collection platform, which helps healthcare professionals focus more on patient care. This device helps healthcare professionals perform a wide variety of processes on a single platform by using continuous-flow centrifugation and optical detection technology. Similarly, Fresenius Medical Care developed the Fenwal Amicus separator, an apheresis device used for mononuclear cell (MNC) collection and therapeutic plasma exchange (TPE). It helps healthcare professionals achieve platelet collections with high precision and accuracy. However, the dearth of skilled professionals to use advanced systems and the expensive nature of these systems are expected to hamper the growth of this segment to a certain extent, which in turn negatively affects the growth of the market during the forecast period.

Application Analaysis 

Numerous conditions affecting the brain, spinal cord, and peripheral nerves are classified as neurological disorders. These conditions include autoimmune diseases such as multiple sclerosis (MS), Guillain-Barre syndrome (GBS), and neuromyelitis optica spectrum disorder (NMOSD). Apheresis devices play a crucial role in managing these disorders by selectively removing harmful substances from the blood, such as autoantibodies and inflammatory cytokines, which contribute to nerve damage and dysfunction. Moreover, apheresis can be used as an adjunctive therapy in other neurological conditions like myasthenia gravis and chronic inflammatory demyelinating polyneuropathy (CIDP), helping to alleviate symptoms and improve patient outcomes. The market for neurological disorders is driven by factors such as the increasing prevalence of these conditions, advancements in such technology enhancing treatment efficacy, and the growing demand for alternative therapies to manage neurological diseases. As the understanding of neurological disorders advances and the need for targeted treatments grows, the demand for neurological applications is expected to rise, boosting the market growth during the forecast period.

Hematological disorders encompass a diverse range of conditions affecting the blood and its components, including leukemia, thrombotic thrombocytopenic purpura (TTP), and hemolytic anemia. Apheresis devices play a critical role in managing these disorders by selectively removing pathogenic components from the blood, such as abnormal cells, antibodies, and excess proteins. In leukemia, apheresis can aid in removing leukemic cells or collecting hematopoietic stem cells for transplantation. Prominent market players offering such devices for this application include Terumo BCT with their Spectra Optia Apheresis System, designed to provide flexibility and efficiency in treating hematological disorders by enabling precise removal and collection of blood components. As the understanding of hematological disorders advances and the need for targeted treatments grows, the demand is expected to continue rising, driving the growth of the market during the forecast period.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 44% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional market trends and drivers that will shape the market during the forecast period. In North America, particularly in the United States and Canada, the market experiences robust growth driven by several key factors. The region witnesses a significant prevalence of cardiovascular diseases (CVDs) and neurological disorders, prompting a higher demand for apheresis devices. Additionally, the rising number of surgical procedures, coupled with the adoption of technologically advanced medical devices, contributes to market expansion. Increased awareness among healthcare professionals about the apheresis procedure further fuels market growth.

In addition, the presence of numerous companies manufacturing devices and ongoing technological advancements in apheresis procedures also play significant roles in driving market growth in North America. Furthermore, private and public organizations in the region actively conduct programs and conferences to raise awareness about apheresis among both healthcare professionals and the general population, thereby stimulating demand for apheresis systems and consumables and fostering the growth of the market in the region during the forecast period. 

Buy Full Report Now

Key Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Asahi Kasei Corp - The company offers apheresis devices such as Plasmaflo OP, Cascadeflo EC, IMMUSORBA TR, IMMUSORBA PH, PLASORBA BR, CUREFLO, and others.

Asahi Kasei Corp., B.Braun SE, BioIVT LLC, Braun and Co. Ltd., Charles River Laboratories International Inc., Fresenius Medical Care AG and Co. KGaA, Haemonetics Corp., Haier Smart Home Co. Ltd., Kaneka Corp., Lmb Technologie GmbH, Mallinckrodt Plc, Medica S.p.A., MICRO TECHNOLOGIES, Miltenyi Biotec B.V. and Co. KG, Nikkiso Co. Ltd., OTSUKA ELECTRONICS CO. LTD, Kawasumi Laboratories Inc., Terumo Corp., and Cerus Corp.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Dynamics and Customer Landscape

The market is driven by the rising prevalence of blood-related disorders like leukemia, lymphoma, and myeloma, necessitating frequent blood transfusions and apheresis therapy. Portable apheresis devices offer flexibility in treatment for patients with autoimmune diseases and cancer. The demand surged during the COVID-19 pandemic for convalescent plasma therapy to treat SARS-CoV-2 infection. However, challenges persist in ensuring accessibility to apheresis equipment and addressing the complexities of therapeutic purposes while maintaining safety standards. Advancements in apheresis machines and disposable apheresis kits are key trends shaping the market landscape. Our researchers analyzed the market research and growth data with 2023  as the base year, along with the key market growth analysis, trends, and challenges. A holistic analysis of drivers, trends, and challenges will help companies refine their marketing strategies to gain a competitive advantage. 

Key Drivers

The growing number of surgical procedures associated with trauma and injury cases is notably driving market growth. In certain cases, surgeries are performed by healthcare professionals to save the lives of patients. Blood loss during surgery is one of the major problems which can lead to the death of patients. Patients with blood loss during the surgery may need a transfusion of blood for recovery, and apheresis is majorly adopted during surgical procedures where autologous blood transfusion is required. The number of surgical procedures has increased across the globe due to the increasing incidence of various diseases. Patients with sickle cell disease, haemophilia, and anaemia may require a transfusion of blood components during or after the surgical procedure due to heavy blood loss probabilities.

In addition, globally, trauma and injury cases are increasing significantly. Injury is one of the leading causes of death in children and the geriatric population. Deaths due to unintentional injuries and physical trauma mainly occur due to severe blood loss. In order to treat patients with injury and trauma, apheresis procedures are majorly performed in emergency departments of hospitals and clinics. These factors are expected to drive the growth of the market during the forecast period.

Significant Trends

Developments in the global apheresis devices industry are an emerging trend shaping market growth. One important trend is the ongoing development of more advanced and effective apheresis devices due to technological advancements. These technological developments are enhancing the precision, safety, and ease of use of apheresis procedures, ultimately improving patient outcomes. For in July 2022, Terumo Blood and Cell Technologies collaborated with Eliaz Therapeutics to research and market a groundbreaking therapeutic apheresis treatment for acute kidney injury (AKI).

Additionally, there is a growing emphasis on the development of disposable kits for apheresis procedures. These disposable kits offer numerous advantages, including reduced risk of infection, enhanced convenience, and improved workflow efficiency. As a result, they are becoming increasingly popular among healthcare providers and are expected to drive growth in the market during the forecast period.

Major Challenges

The shortage of donors required for the apheresis process is a significant challenge hindering market growth. It is one of the gold standards used for the transfusion of various types of blood components depending on the needs of patients for therapeutic purposes. This procedure majorly involves the collection of blood from donors. Donors who participate in the apheresis procedure may face certain complications, such as bleeding, infection at the site, low blood pressure, and muscle cramping. The complications associated with this process and lack of awareness about apheresis are hindering the market growth.

However, technological advances in products and procedures, and limited awareness among donors about the process hinder the growth of the market. Social stigma and myths associated with the donation of blood components create an obstacle to the growth of the process. Moreover, the growing sedentary lifestyle leads to the development of various chronic lifestyle diseases among people across the globe. The population with such diseases is not allowed to donate blood for the process. These factors are expected to restrict the growth of the market during the forecast period.

Buy Now Full Report

Key Market Customer Landscape

The market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth and forecasting strategies.

 Customer Landscape

Segment Overview

The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 20287. 

• Product Outlook
  • Systems
  • Consumables

• Application Outlook
  • Neurological disorders
  • Haematological disorders
  • Renal disorders
  • Autoimmune disorders

• Region Outlook
  • North America
    • The U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • India
  • Rest of World (ROW)
    • Brazil
    • Argentina
    • Australia

Market Analyst Overview

The market is propelled by the increasing demand for therapeutic procedures like photopheresis treatments and extracorporeal photopheresis immunotherapy (ECP) for conditions such as Graft-Versus-Host Disease (GVHD) and hematologic disorders. With advancements in gene therapies and Chimeric Antigen Receptor (CAR) T-cell therapies, apheresis devices play a crucial role in mononuclear cell collection (MNC) and continuous mononuclear cell collection (CMNC). Additionally, the market caters to the treatment of various diseases, including sickle cell disease (SCD) and blood cancer, supported by organizations like the Leukemia & Lymphoma Society (LLS). Automated devices enhance efficiency in platelet donors and therapeutic plasma exchange procedures, ensuring safe and effective treatments for trauma cases and chronic diseases. The market's growth is further fueled by the continuous innovation in membrane separation equipment and the widespread presence of blood donation centers. Also, the market is driven by demand for RBC units, critical for patients and blood donors. These devices play a crucial role in collecting blood components for vaccines and drugs.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Market Research Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the between 2024 and 2028
• Precise estimation of the size and its contribution of the market in focus to the parent market
• Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
• Companies landscape comparing criticality of inputs and factors of differentiation
• Exclusive Matrix on companies position and classification
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the market industry across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the growth of companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch